# EXPERT, EXPosurE Registry RiociguaT in Patients With Pulmonary Hypertension

> **NCT02092818** · — · COMPLETED · sponsor: **Bayer** · enrollment: 1316 (actual)

## Conditions studied

- Hypertension, Pulmonary

## Interventions

- **DRUG:** Riociguat (Adempas, BAY63-2521)

## Key facts

- **NCT ID:** NCT02092818
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05-31
- **Primary completion:** 2018-03-31
- **Final completion:** 2018-06-29
- **Target enrollment:** 1316 (ACTUAL)
- **Last updated:** 2019-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02092818

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02092818, "EXPERT, EXPosurE Registry RiociguaT in Patients With Pulmonary Hypertension". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT02092818. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*